Ghana's president Nana Akufo-Addo on Monday became the world's first recipient of a coronavirus vaccine from Covax, a global scheme to procure and distribute inoculations for free for poorer countries.
Richer countries have surged ahead with inoculating their population, but many poorer countries are still awaiting their first vaccine doses.
"It is important that I set the example that this vaccine is safe by being the first to have it, so that everybody in Ghana can feel comfortable about taking this vaccine," the 76-year old president said before receiving a shot of Oxford/AstraZeneca vaccine in a live broadcast.
First lady Rebecca Akufo-Addo also received a shot, one day before the rest of the 600,000 doses are deployed across the country.
"Fellow Ghanaians, I know there are still some who continue to express doubts about the vaccine, others have expressed reservations about its efficacy, with some taking sides with conspiracy theorists who believe the vaccine has been created to wipe out the African race. This is far from the truth," the president said in a nationwide address on Sunday night.
"Taking the vaccine will not alter your DNA, it will not embed a tracking device in your body, neither will it cause infertility in women or in men," he said.
Ghana's food and drug authority last month authorized the Indian-made vaccine and Russia's Sputnik V, as the government aims to target 20 of its 30 million population by year's end.
Last Wednesday, Ghana was the first country to receive vaccines from Covax, led by Gavi the Vaccine Alliance, the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI).
Some 145 participating economies are set to receive 337.2 million doses by mid-year -- enough to vaccinate a little over three percent of their combined populations.
Covax has said it hopes to raise the figure to up to 27 percent in lower-income countries by the end of December.
Ghana has recorded 84,023 Covid-19 cases and 607 deaths since the start of the pandemic.